It could be what causes Johnson & Johnson blood clots, the researcher says
A researcher compared the reaction that causes clots "awakening a sleeping dragon".
With the Johnson & Johnson vaccine on the market and widely distributed across the United States, researchers are still trying to classify why the vaccine has caused rare but serious blood clots. Disease Control and Prevention Centers (CDC) and US Food and Medicine Administration (FDA)considered the safe vaccine And effective, with its advantages overwhelmed the potential risks. However, scientists are impatient to learn more about the phenomenon of blood clots - and a German expert thinks he has found the link between Johnson & Johnson vaccine and blood clots.
RELATED:If you have this type of blood, you are more likely to get blood clots.
Blood expertAndreas Greinacher, MD, believes he has identified what iscausing blood clots In Johnson & Johnson and Astrazeneca Beneficiaries, according toWall Street newspaper. Greinacher, with his team at the University of Greifswald,published a study April 9 inNew England Journal of Medicine. The team proposed that viral vector vaccines, which use modified viruses to transfer genetic materials via vaccination, could result in an autoimmune response that causes blood clots. Johnson & Johnson and Astrazeneca vaccines are both viral vector vaccines, while Pfizer and Moderna vaccines areMRNA vaccines This work using different mechanisms.
According toScientific magazine, Greinacher and his team believe that blood clots could be linked towandering proteins and a specific preservative. Although they are only starting to study Johnson & Johnson's vaccine, they have made significant discoveries about the AstraZeneca vaccine, which is very similar to Johnson & Johnson. ThroughWall Street newspaperThe team observed more than 1,000 proteins in the Human Cell Derivative Vaccine. The researchers also found the Conservative ethylenededestraacetic acid (EDTA) in the vaccine, which could be the key to understanding blood clots.
Greinacher hypothetic that EDTA helps human cell proteins stopping in the bloodstream-once there, they bind to a blood component called platelet factor. The inflammation that can come from the vaccine, combined with the platelet factor four, could confuse the immune system, which thinks the body has been infected. This can in turn trigger an "archaic defense mechanism that lacks control and causes coagulation and bleeding"Wall Street newspaper reports. Greinacher compared this reaction to "awakening a sleeping dragon".
RELATED:For more information up to date, sign up for our daily newsletter.
While more and more research needs to be done to understand the complexity of the blood clots that follow vaccination, these results can help points researchers in the right direction. Finding the precise reason these rare blood clots are needed to help vaccine recipients and health experts make risk assessments and provide care. In addition, determining what causes the causes of blood clots to inform future vaccines. "The understanding of the cause is of greater importance for new generation vaccines because [the novel] Coronavirus will remain with us and vaccination will probably become seasonal"Eric Van Gorp, PhD, Professor at Erasmus University in the Netherlands, saidWall Street newspaper.
To continue learning more about the connection, a Johnson & Johnson spokesman saidWall Street newspaper That the company examines a potential collaboration with Greinacher.
RELATED:If you take this medicine, you are more likely to get a blood clot.
